Sovereign Health of Rancho San Diego Welcomes

 Suzanne Jessee, M.A., CTMS 

Presenting: "A New Era in Treating Depression – Transcranial Magnetic Stimulation"

Major Depressive Disorder is the leading cause of adult disability in America, accounting for $210 billion in economic burdens. The first line of treatment has traditionally been antidepressant medications. The likely hood of receiving remission with antidepressants is limited and declines with each successive treatment attempt.  Deep Transcranial Magnetic Stimulation (dTMS) offers new hope for treatment-resistant depression. dTMS was FDA approved in 2008. Clinical trials indicate consistent 50 percent remission outcomes and as high as 75 percent response to treatment. dTMS is a noninvasive, well-tolerated breakthrough in treatment for depression.

Bio
Suzanne Jessee is the Chief Strategy Officer for Achieve TMS and has worked exclusively in chemical dependency and dual diagnosis treatment centers like the world-renowned Betty Ford Center, Brighton Hospital, Foundations Recovery Network’s Michael’s House, Dawn Farms and volunteered at many more. Suzanne earned her Bachelor of Science in psychology at Eastern Michigan University and her master’s at Hazelden School for Addiction Studies as a Licensed Professional Counselor and is a Certified Hypnotherapist. She has helped literally thousands of people suffering with the debilitating effects of anxiety to find peace of mind, body and spirit using the ESCAPE Anxiety program

Course Objectives:

• Explain traditional treatment options for major depressive disorder.
• Discuss Neuromodulation and TMS.
• Identify treatment candidates for dTMS.

_____________________________________________________________________________

There is no commercial support for this program nor are there any relationships between the CE Sponsor, presenting organization, presenter, programcontent, research, grants or other funding that could reasonably be construed as conflicts of interest.